Edwards Lifesciences Corporation (BVMF:E1WL34)
Brazil · Delayed Price · Currency is BRL 111.86
-0.89 (-0.79%)
At close: Dec 3, 2025
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of 258.44 billion as of December 4, 2025. Its market cap has increased by 14.67% in one year.
Market Cap
258.44B
Enterprise Value
241.75B
Revenue
31.36B
Ranking
n/a
PE Ratio
35.45
Stock Price
111.86
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from 1.67B to 258.44B, an increase of 15,384.16%. That is a compound annual growth rate of 21.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 262.74B | -2.71% |
| Dec 31, 2024 | 270.05B | 20.34% |
| Dec 29, 2023 | 224.40B | -7.98% |
| Dec 30, 2022 | 243.86B | -45.89% |
| Dec 31, 2021 | 450.65B | 52.62% |
| Dec 31, 2020 | 295.28B | 50.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 102.90B |
| Raia Drogasil | 41.13B |
| Hypera | 16.96B |
| Fleury | 8.75B |
| Odontoprev | 6.32B |
| Empreendimentos Pague Menos | 3.89B |
| Diagnósticos da América | 3.75B |
| Blau Farmacêutica | 2.33B |